Influence of Ranibizumab versus laser photocoagulation on radiation retinopathy (RadiRet) - a prospective randomized controlled trial

PURPOSE: To demonstrate superiority of intravitreal ranibizumab 0.5 mg compared to focal and peripheral laser treatment in patients with radiation retinopathy for choroidal melanoma. METHODS: Inclusion criteria were as follows: patients with radiation retinopathy and visual acuity impairment due to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Graefes Arch Clin Exp Ophthalmol
Autors principals: Seibel, Ira, Vollhardt, Daniela, Riechardt, Aline I., Rehak, Matus, Schmied, Sabine, Schiller, Petra, Zeitz, Oliver, Hellmich, Martin, Joussen, Antonia M.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2020
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7575494/
https://ncbi.nlm.nih.gov/pubmed/32112140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00417-020-04618-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars